All terms in GO
| Label | Id | Description |
|---|---|---|
| regulation of potassium ion concentration by positive regulation of transcription from RNA polymerase II promoter | GO_0097301 | [Any process that regulates the internal concentration of potassium ions at the level of a cell by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.] |
| lipoprotein biosynthetic process via diacylglyceryl transfer | GO_0097302 | [The chemical reactions and pathways by which diacylglyceryl transfer leads to formation of a water-soluble protein-lipid complex.] |
| lipoprotein biosynthetic process | GO_0042158 | [The chemical reactions and pathways resulting in the formation of any conjugated, water-soluble protein in which the covalently attached nonprotein group consists of a lipid or lipids.] |
| positive regulation of paraxial mesodermal cell fate determination | GO_0048346 | [Any process that activates or increases the frequency, rate or extent of paraxial mesoderm cell fate determination.] |
| regulation of paraxial mesodermal cell fate determination | GO_0048345 | [Any process that modulates the frequency, rate or extent of paraxial mesoderm cell fate determination.] |
| paraxial mesodermal cell fate determination | GO_0048344 | [The process in which a cell becomes capable of differentiating autonomously into a paraxial mesoderm cell regardless of its environment; upon determination, the cell fate cannot be reversed.] |
| lipoprotein biosynthetic process via N-acyl transfer | GO_0097303 | [The chemical reactions and pathways by which N-acyl transfer leads to formation of a water-soluble protein-lipid complex.] |
| negative regulation of paraxial mesodermal cell fate determination | GO_0048347 | [Any process that stops, prevents, or reduces the frequency, rate or extent of paraxial mesoderm cell fate determination.] |
| lipoprotein biosynthetic process via signal peptide cleavage | GO_0097304 | [The chemical reactions and pathways by which signal peptide cleavage leads to formation of a water-soluble protein-lipid complex.] |
| paraxial mesodermal cell fate commitment | GO_0048343 | [The process in which a cell becomes committed to become a paraxial mesoderm cell.] |
| cellular response to alcohol | GO_0097306 | [Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alcohol stimulus.] |
| cellular response to organic substance | GO_0071310 | [Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.] |
| response to farnesol | GO_0097307 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a farnesol stimulus.] |
| cellular response to farnesol | GO_0097308 | [Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a farnesol stimulus.] |
| cap1 mRNA methylation | GO_0097309 | [Methylation of the ribose of the first nucleotide of a 5'-capped mRNA.] |
| cap mRNA methylation | GO_0036451 | [Methylation of the 2'-O-ribose of the first or second transcribed nucleotide of a 5'-capped mRNA.] |
| paraxial mesodermal cell differentiation | GO_0048342 | [The process in which a relatively unspecialized cell acquires the specialized features of a paraxial mesoderm cell.] |
| paraxial mesoderm formation | GO_0048341 | [The process that gives rise to the paraxial mesoderm. This process pertains to the initial formation of the structure from unspecified parts.] |
| mesenchyme morphogenesis | GO_0072132 | [The process in which the anatomical structures of a mesenchymal tissue are generated and organized. A mesenchymal tissue is made up of loosely packed stellate cells.] |
| tobramycin catabolic process | GO_1901120 | [The chemical reactions and pathways resulting in the breakdown of tobramycin.] |